There’s No Getting Around Structure Therapeutics Inc ADR (NASDAQ: GPCR) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

GPCR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Structure Therapeutics Inc ADR is $1.75B. A total of 0.88 million shares were traded on the day, compared to an average of 0.93 shares.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for GPCR in the last 3 months, the mean price target is $80.80 with high estimates of $93.00 and low estimates of $58.00. In terms of 52-week highs and lows, GPCR has a high of $75.02 and a low of $20.80.

As of this writing, GPCR has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.6 in the last quarter, which was -114.30% lower than expectations of -$0.28.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GPCR’s latest balance sheet shows that the firm has $107.31M in Cash & Short Term Investments as of fiscal 2021. There were $621.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $5.37, while its Total Shareholder’s Equity was -$64.73M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GPCR is Buy with a score of 5.00.

Most Popular

Related Posts